🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Study to investigate the safety, tolerability and pharmacokinetics of GSK59...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-06-09
Trial ID
NCT00728052
The purpose of this study is to determine how the organism affects MMF (met...
Status
Completed
Location
Almirall Investigational Site #1
Start Date
2016-09
Trial ID
NCT02955693
Treatments Being Tested
The purpose of this study is to evaluate the bioequivalence of metformin co...
Status
Completed
Location
Multiple Locations
Start Date
2014-08
Trial ID
NCT02221180
The inhaled route of delivery has always been associated with the considera...
Status
Unknown
Location
Songklanagarind Hospital
Start Date
2013-02
Trial ID
NCT01785927
Treatments Being Tested
This study will evaluate the Pharmacokinetics (PK) of the Phase II tablet f...
Status
Completed
Location
Nuvisan GmbH
Start Date
2019-04-15
Trial ID
NCT03934502
Treatments Being Tested
The purpose of this study is to determine the relative oral bioavailability...
Status
Completed
Location
Multiple Locations
Start Date
2009-08
Trial ID
NCT00946842
Treatments Being Tested
The purpose of this study is to assess the effect of antacid administration...
Status
Completed
Location
Multiple Locations
Start Date
2015-03
Trial ID
NCT02382640
Treatments Being Tested
The main objective of this trial is to investigate the relative bioavailabi...
Status
Completed
Location
Humanpharmakologisches Zentrum Biberach
Start Date
2019-02-11
Trial ID
NCT03817476
Treatments Being Tested
2 different formulations and 4 different single doses of tafamidis will be ...
Status
Completed
Location
Pfizer Clinical Research Unit
Start Date
2018-09-28
Trial ID
NCT03662191
Treatments Being Tested
The primary purpose of the study is to investigate the plasma pharmacokinet...
Status
Completed
Location
Multiple Locations
Start Date
2016-10
Trial ID
NCT02930694
Treatments Being Tested